Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Cancer Causes Control. 2022 Apr;33(4):559-582. doi: 10.1007/s10552-021-01549-4. Epub 2022 Jan 4.
A disparity exists in cancer screening rates for the Sexual and Gender Minority (SGM) community. We sought to understand the perceptions and baseline knowledge of cancer screening among SGM community members.
Survey administered via social media from June 2018 to October 2018. We asked 31 questions focused on cancer screening, human papillomavirus, emotional distress, and experience with the health care system. Those included were 18 years or older. Cancer screening attitudes and knowledge, as well as perceptions of the health care system were investigated.
There were 422 respondents analyzed: 24.6% identified as female, 25.5% as male, 40.1% transgender, and 9.6% as other. 65.4% of the SGM community is not certain what cancer screening to do for themselves. Only 27.3% and 55.7% knew that HPV was a risk factor associated with head and neck cancer and anal cancer, respectively. Half stated their emotional distress prevents them from getting cancer screening. It was identified that process changes in making appointments, comforts during the visit, and formal training for physicians and nurses could increase cancer screening compliance for this community. The transgender population had a trend in more gaps in knowledge of appropriate cancer screening and significant excess emotional distress.
Gaps in cancer screening knowledge and emotional and financial distress may be responsible for the disparity of lower cancer screening rates for the SGM population and the transgender population may be most at risk. Appreciating the cancer screening concerns of the SGM population can help shape future clinical and institutional approaches to improve health care delivery.
性少数群体(SGM)的癌症筛查率存在差异。我们试图了解 SGM 群体成员对癌症筛查的看法和基本知识。
2018 年 6 月至 10 月通过社交媒体进行调查。我们提出了 31 个问题,重点关注癌症筛查、人乳头瘤病毒、情绪困扰以及对医疗保健系统的体验。参与者年龄在 18 岁及以上。我们调查了癌症筛查态度和知识,以及对医疗保健系统的看法。
共分析了 422 名受访者:24.6%为女性,25.5%为男性,40.1%为跨性别者,9.6%为其他。65.4%的 SGM 群体不确定自己应该进行哪些癌症筛查。只有 27.3%和 55.7%的人知道 HPV 是与头颈部癌症和肛门癌相关的风险因素。有一半的人表示情绪困扰会阻止他们进行癌症筛查。研究发现,预约流程、就诊时的舒适度以及医生和护士的正式培训方面的改变,可以提高该群体的癌症筛查率。跨性别者群体在适当的癌症筛查知识和明显的过度情绪困扰方面存在更多差距。
癌症筛查知识的差距以及情绪和经济困扰可能是 SGM 人群癌症筛查率较低的原因,而跨性别者群体的风险可能最大。了解 SGM 群体的癌症筛查关注点有助于形成未来改善医疗保健服务的临床和机构方法。